The Objective Response Rate (ORR) is a critical measure used in oncology to evaluate the efficacy of cancer treatments. It represents the proportion of patients whose tumor size is reduced by a predefined amount and for a specified minimum time. ORR is commonly used in clinical trials to assess the impact of new cancer therapies.
